Document Detail


Malignancy and Radiation-Induced Cardiotoxicity.
MedLine Citation:
PMID:  22044038     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Mediastinal mass radiotherapy as adjuvant or primary treatment is usually performed for lung, breast and oesophagus cancer, for lymphoma and thymoma. However, untoward late cardiac and vascular adverse effects can develop that were underrecognized in the past because a very long latency from exposure to clinical manifestations is needed. Moreover, the true cumulative incidence of these complications is hard to correctly evaluate. Thoracic Radiotherapy (TR) may determine pathological involvement of pericardium, myocardium, cardiac valves, conduction system, coronary arteries and of subclavian and carotid arteries. The main clinical features of radiation induced cardiac and vascular diseases are discussed in the review. Recently, an increased risk of strokes and transient ischemic attacks (TIAs) has also been shown after TR, and the possible mechanisms as well as the measures useful in decreasing the risk are discussed. Other emerging aspects of radiation induced damages, just like malfunction of Pace Maker and of Implantable Defibrillators as well as malfunction of coronary bypass and coronary stents, probably will become more frequent in the next future. Finally, the current knowledge concerning the effects of the new modalities of administration of TR (doses, techniques) on the cardiovascular risk is reported, as well as the important clinical problem linked to the appropriate evaluation of the risk/benefit ratio of performing TR in different clinical situations.
Authors:
L Mancuso; A Mancuso; F Scordato; M Pieri; M Ce Valerio
Related Documents :
1556588 - Advances and controversies in cardiopulmonary resuscitation in the young.
17413048 - Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism.
17697738 - Sternal fracture and osteomyelitis: an unusual complication of a precordial thump.
3212768 - Cerebral function analysis during deep hypothermia and total circulatory arrest in infa...
7955208 - Relation between shock-related myocardial injury and defibrillation efficacy of monopha...
20600148 - Oxygen and oxygenation in stem-cell therapy for myocardial infarction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-26
Journal Detail:
Title:  Cardiovascular & hematological disorders drug targets     Volume:  -     ISSN:  1871-529X     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-11-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101269160     Medline TA:  Cardiovasc Hematol Disord Drug Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Cardiology, Ospedale V. Cervello, Palermo, Italy. mancandrea@libero.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight fr...
Next Document:  Regulation of endothelial nitric oxide synthase in pathophysiological conditions.